Raquel Ciuvalschi Maia Selected Research

Infections

12/2015

An unusual long-term outcome of a child with primary myelofibrosis harboring a JAK2 mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raquel Ciuvalschi Maia Research Topics

Disease

17	Neoplasms (Cancer) 04/2023 - 01/2004
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 11/2008
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2021 - 07/2010
4	Leukemia 08/2012 - 06/2008
2	Breast Neoplasms (Breast Cancer) 10/2019 - 10/2016
1	Lung Neoplasms (Lung Cancer) 09/2022
1	Carcinogenesis 09/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Disease Progression 01/2020
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2020
1	Infections 12/2015
1	Splenomegaly 12/2015
1	Primary Myelofibrosis (Myelosclerosis) 12/2015
1	Anemia 12/2015
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2014
1	Blast Crisis (Blast Phase) 12/2012
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2012
1	Neoplasm Metastasis (Metastasis) 12/2011
1	Medulloblastoma 12/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2010
1	Lymphoid Leukemia 07/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2009
1	Glioma (Gliomas) 11/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2003

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 04/2021 - 06/2008
9	SurvivinIBA 01/2020 - 11/2008
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2013 - 06/2008
5	Imatinib Mesylate (Gleevec)FDA Link 12/2016 - 11/2008
3	Transcription Factors (Transcription Factor)IBA 12/2019 - 11/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2023 - 01/2023
2	LQB 118IBA 12/2019 - 11/2014
2	11a-N-tosyl-5-deoxi-pterocarpanIBA 10/2019 - 10/2016
2	ParaffinIBA 04/2018 - 01/2004
2	Annexin A5IBA 12/2012 - 10/2011
2	Vincristine (Oncovin)FDA LinkGeneric 08/2012 - 10/2011
2	multidrug resistance-associated protein 1IBA 05/2011 - 11/2008
2	DNA (Deoxyribonucleic Acid)IBA 10/2009 - 01/2004
1	MST 312IBA 09/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	OsteopontinIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	Formaldehyde (Formol)FDA Link 04/2018
1	Antineoplastic Agents (Antineoplastics)IBA 10/2016
1	Janus Kinase 2IBA 12/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2012
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2011
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 05/2011
1	Monoclonal AntibodiesIBA 07/2010
1	AntioxidantsIBA 11/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2008
1	Inhibitor of Apoptosis ProteinsIBA 11/2008
1	Zoledronic Acid (Zometa)FDA Link 06/2008
1	Pamidronate (Aredia)FDA LinkGeneric 06/2008
1	Diphosphonates (Bisphosphonates)IBA 06/2008

Therapy/Procedure

2	Therapeutics 09/2022 - 08/2003
1	Radiotherapy 04/2018
1	Splenectomy 12/2015